School of Medicine
Showing 301-400 of 1,556 Results
-
Igor D. Bandeira
Postdoctoral Scholar, Psychiatry
BioIgor D. Bandeira, M.D., Ph.D., is a Postdoctoral Research Fellow in the Department of Psychiatry and Behavioral Sciences at Stanford University. With extensive experience in interventional psychiatry, Dr. Bandeira has led multiple clinical trials focused on noninvasive brain stimulation and rapid-acting antidepressants for psychiatric disorders in children, adolescents, and adults. He received the prestigious Professor Alfredo Thomé de Britto Award in recognition of his exceptional research achievements during his physician-scientist training at the Federal University of Bahia in Salvador, Brazil.
As part of his medical training, Dr. Bandeira also studied at the University of Sydney (Australia) on a Science Without Borders Scholarship, where he enhanced his clinical and research skills at the university’s Brain and Mind Centre. Upon returning to Brazil, he gained valuable clinical experience as an attending physician with the Brazilian Ministry of Health and worked on the frontlines during the COVID-19 pandemic.
At Stanford, working with Dr. Nolan R. Williams, Dr. Bandeira led the Wellcome LEAP trial on accelerated intermittent theta-burst stimulation (Stanford Neuromodulation Therapy) to treat anhedonic depression. Alongside Dr. Alan F. Schatzberg, he is co-leading a trial supported by the American Foundation for Suicide Prevention, evaluating the efficacy and safety of buprenorphine in sustaining the antisuicidal effects of ketamine. His work centers on developing personalized therapeutics for treatment-resistant depression, bipolar depression, and suicidal behavior.
Looking ahead, Dr. Bandeira plans to apply for psychiatry residency programs in the United States to advance his career in academic psychiatry and clinical research. -
Ramzi Emanuel Dudum
Member (Postdoc), Cardiovascular Institute
BioDr. Dudum is a cardiologist and population health expert working to develop novel risk prediction methods and implementation strategies to create practices and systems that allow for reductions in cardiovascular disease. He completed a Masters in Public Health at Johns Hopkins concentrating in epidemiology and biostatistics and a Doctorate of Medicine at George Washington University.
He completed internal medicine residency training as part of the Osler Medical Service, where he worked under the mentorship of Drs. Roger Blumenthal and Michael Blaha to study improving cardiovascular risk prediction and coronary artery calcium. Given his focus on population health and implementation science, he also helped launch and refine risk adjustment tools and implemented guideline-directed medical care pathways. During his time there, he was recognized for his clinical acumen and dedication to patient care.
He came to Stanford for his cardiovascular medicine fellowship and continued research in coronary artery calcium under the mentorship of Drs. David Maron and Fatima Rodriguez while also conducting cardiovascular health implementation science work under the mentorship of Dr. Steve Asch. He serves as the co-investigator of a prospective randomized trial testing the effects of notification of incidental coronary artery calcium on statin initiation rates among those with and without cardiovascular disease (NCT 05588895). He has worked with hospital leaders to implement digital health and artificial intelligence tools, creating the infrastructure for the prospective use of AI-algorithms on radiology studies. As a preventive cardiologist and population health expert, he leads efforts in the preventive cardiology section related to improving cardiovascular health. -
Caroline Duncombe
Postdoctoral Scholar, Immunity Transplant Infection
BioDr. Caroline Duncombe is a Postdoctoral Scholar in the Institute for Immunity, Transplantation, and Infection at Stanford University. Her research broadly explores how sex-based differences influence immune responses to infectious diseases. She applies systems-level approaches to investigate molecular and cellular mechanisms underlying immune variation, with the goal of informing more equitable and effective interventions.
Dr. Duncombe earned her PhD in Pathobiology from the University of Washington, where she pursued interdisciplinary research integrating systems biology, immunology, epidemiology, endocrinology, and parasitology. Her work has contributed to a deeper understanding of how sex and sex hormones shape host-pathogen interactions and vaccine responses.
In addition to her academic research, Dr. Duncombe is committed to science communication. She has produced science-focused comedy shows for over four years, using storytelling and humor to make complex scientific ideas more accessible.
Personal Website: carolinethescientist.com
LinkedIn Profile: linkedin.com/in/caroline-duncombe-phd-4ba11a124 -
Sebastian Duno-Miranda
Postdoctoral Scholar, Biochemistry
BioPlease see https://duno-miranda.org
-
Ifeanyichukwu Emmanuel Eke
Postdoctoral Scholar, Pathology
BioI am a chemical biologist with a broad interest in defining the mechanisms-of-action of novel compounds that can be used as potential drugs or diagnostic probes for different bacterial and viral infections. In addition to my flair for research, I am passionate about teaching, mentorship, leadership, and entrepreneurship.
-
Ahmet Görkem Er
Postdoctoral Scholar, Radiology
BioAhmet Görkem Er, M.D., Ph.D., is a physician-scientist and postdoctoral fellow in Integrative Biomedical Imaging Informatics (IBIIS) at Stanford University. He graduated from Istanbul University Faculty of Medicine and completed dual residency training in internal medicine and infectious diseases and clinical microbiology at Hacettepe University. He also has a Ph.D. in medical informatics from Middle East Technical University.
As a Fulbright Ph.D. Dissertation Research Grantee (2022–2023), Dr. Er conducted research at the Stanford Center for Biomedical Informatics Research, focusing on multimodal data integration in COVID-19 patients. This work resulted in a publication in NPJ Digital Medicine demonstrating the value of combining clinical, imaging, and viral genomic data for improved disease modeling. He returned to Stanford in 2024 as a visiting researcher and is currently a postdoctoral fellow, where he combines his clinical background with advanced computational methods.
Dr. Er’s research focuses on developing artificial intelligence and multimodal data fusion approaches for complex diseases. His work integrates a broad spectrum of inputs, including medical imaging, histopathology, clinical data, genomics, and spatial transcriptomics, to improve patient stratification and support data-driven clinical decision-making. -
Ali Etemadi
Postdoctoral Scholar, Nephrology
Current Research and Scholarly InterestsI am a clinician and data scientist focusing on drawing causal inferences from observational data when randomized controlled trials are not feasible. Currently, my work centers on patients with late-stage chronic kidney disease, a rapidly growing population for which evidence is limited due to their frequent exclusion from RCTs. At the moment, I aim to move towards precision medicine approaches to optimize outcomes for these patients.
-
Palmer Feibelman
Postdoctoral Scholar, Ophthalmology
BioPalmer Feibelman studied biomedical engineering at Georgia Tech before earning his medical degree from the Medical College of Georgia. He went on to serve as a medical officer in the U.S. Navy, where he held the role of Medical Department Head at Navy Operational Support Center Washington, D.C., and later deployed as a flight surgeon with Marine F/A-18 squadron VMFA-232. Following his military service, he pursued ophthalmology training at Brown University, where he also continued to build on his engineering background. He is now the Ophthalmology Innovation Fellow at Stanford University for the 2025–2026 academic year.
-
Emily Ferguson, PhD
Postdoctoral Scholar, Psychiatry
BioEmily Ferguson, Ph.D., is a postdoctoral academic researcher and clinician within Stanford University’s Autism and Developmental Disorders Research Program (https://med.stanford.edu/autism.html) within the Department of Psychiatry and Behavioral Sciences. She earned her doctoral degree in Clinical Psychology from the University of California Santa Barbara and completed her clinical internship at the University of California Los Angeles. Dr. Ferguson's research focuses on advancing understanding of mechanisms of challenging behaviors in autistic youth and adults to inform treatment development. Her work takes a comprehensive perspective, integrating methods from implementation science to improve the accessibility and quality of clinical care for underserved autistic populations, especially those with higher support needs (or "profound autism"). She is also interested in developing methods to improve self-regulation in individuals with profound autism to effectively manage self-injurious behaviors and aggression. Dr. Ferguson is currently supporting research in the Preschool Autism Lab (https://med.stanford.edu/autismcenter/pre-school-autism-lab-program.html), and exploring profiles of challenging behaviors with the Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) in a diverse range of autistic and non-autistic youth to inform treatment approaches.
-
Lorenzo Ferrari
Postdoctoral Scholar, Cardiothoracic Surgery
BioLorenzo Ferrari, PhD, is a biomedical engineer interested in cardiovascular flows and in developing benchtop systems for in vitro evaluation of cardiac devices. His current postdoctoral research in the Department of Cardiothoracic Surgery at Stanford University focuses on simulating and testing transcatheter valves implanted in the right ventricular outflow tract using 4D Flow MRI, working with Doff B. McElhinney, Daniel B. Ennis, and Alison L. Marsden. He obtained his PhD summa cum laude in Biomedical Engineering from the University of Bern, where he investigated the influence of heart valve design and size under different hemodynamic conditions using particle velocimetry techniques. During his PhD, he completed a secondment at the University of Twente in the Physics of Fluids group at the Max Planck Center for Complex Fluid Dynamics, collaborating with Michel Versluis and Guillaume Lajoinie to assess the stability of flow fields past valve prostheses.
-
Dorien Feyaerts
Instructor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsBiomedical scientist and immunologist with a strong background in fetal-maternal immunology that aims to conduct impactful translational research in women’s health to improve the health of mothers and their children.
-
Priya Fielding-Singh
Postdoctoral Scholar, SCRDP/ Heart Disease Prevention
BioI am a Sociologist and Postdoctoral Fellow in Cardiovascular Disease Prevention at the Stanford Prevention Research Center. My research examines health, gender, and social inequality.
My primary research agenda investigates health disparities across class, race, and gender in the United States. I draw on both qualitative and quantitative methods to understand how neighborhoods, schools, and families shape our health behaviors and outcomes. My work has been published in journals such as Social Science & Medicine, Obesity, Sociological Science, and the Journal of Adolescent Health.
I hold a Ph.D. in Sociology from Stanford University, a M.A. in Anthropology from the University of Bremen, and a B.S. in Education and Social Policy from Northwestern University. -
Adina S. Fischer, MD, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Fischer’s research focuses on characterizing risk and resilience factors in depression. She has been awarded an NIH Career Development Award (K23) and Klingenstein Foundation Fellowship in Adolescent Depression to build her program of clinical and translational research at Stanford. Dr. Fischer's program of clinical care focused on the delivery and teaching of evidence-based clinical interventions that enhance resilience, with a focus on addressing the unique stressors encountered in academia and academic medicine that may contribute to risk and resilience in mood and anxiety disorders.
Dr. Fischer’s translational program of research focuses on:
(1) Improving our understanding of protective biomarkers of resilience to depression
(2) Characterizing the effects of cannabis on neurobiological function and depressive symptoms
(3) Developing neurobiologically-guided interventions for depressive disorders, particularly those that co-occur with cannabis and other substance use
Dr. Fischer earned her BSc at the Massachusetts Institute of Technology in Brain and Cognitive Sciences, where she conducted research in the Early Childhood Cognition Laboratory. She then completed the MD/PhD Program at Dartmouth, where she obtained her PhD in in Neuroscience. Dr. Fischer’s doctoral research focused on characterizing the acute effects of cannabis in patients with schizophrenia and co-occurring cannabis use disorder. She then completed the Stanford Psychiatry Residency Training Program as a member of the Research Track, and an NIH funded T-32 postdoctoral research fellowship within the Department of Psychiatry and Behavioral Sciences. -
Jelle Folkerts
Postdoctoral Scholar, Pathology
BioDr. Folkerts received his master's degree in Drug Innovation from Utrecht University in the Netherlands, during which he spent a year at the Galli lab at Stanford on a Fulbright Scholarship. During this time, Dr. Folkerts played a key role in developing a technology platform employing functional genomics and high-resolution single-cell confocal imaging, enabling the rapid identification of degranulation regulators in primary human mast cells. Following his time at Stanford, Dr. Folkerts studied the regulatory mechanisms of human mast cell activation under the guidance of Rudi Hendriks and Marcus Maurer, earning his Ph.D. in 2022. He then returned to Stanford as a postdoctoral fellow in the Galli lab, where his current research focuses on the identification of human mast cell degranulation regulators using a whole-genome CRISPR knockout library screen, and the validation of these findings using the recently developed technology platform. It is his long-standing goal to contribute to the design and development of specific and effective therapeutic interventions for mast cell-mediated diseases.
-
Daiana Fornes
Postdoctoral Scholar, Pulmonary
BioDaiana Fornes is a postdoctoral scholar at Stanford University, supported by a Maternal & Child Health Research Institute (MCHRI) Postdoctoral Fellowship. Her research centers on reproductive biology and pregnancy disorders, with a particular focus on uterine contractility, preterm labor, and uterine atony. She investigates calcium signaling pathways, including the role of TRPV4 ion channels, to identify novel therapeutic strategies aimed at improving maternal health outcomes.
Daiana earned her PhD from the University of Buenos Aires, where she studied metabolic alterations during pregnancy and their effects on fetal development. Her training has provided her with a strong foundation in translational research, with extensive experience in experimental design, molecular biology, and the analysis of signaling pathways. -
Ines Forrest
Postdoctoral Scholar, Stanford Cancer Institute
BioI completed a dual Master's Degree in Chemistry/Biochemistry (University of Oklahoma) and Organic Chemistry/Chemical Engineering (Sigma-Clermont), as well as a Ph.D. in Chemical and Biological Sciences (The Scripps Research Institute). As a postdoctoral research fellow at Stanford in Prof. Nathanael Gray's lab, I look forward to applying my skills in chemical proteomics, chemistry, and molecular biology to drive impactful research at the interface of chemistry and medicine and develop pioneering solutions to improve human health.
-
Jenna Forsyth
Director, Project Unleaded, Human and Planetary Health
BioJenna Forsyth, PhD, is an interdisciplinary environmental health scientist. She has focused on lead exposure research for 10 years and currently oversees the research portfolio for Project Unleaded - an initiative to identify and mitigate priority sources of lead poisoning globally, with an emphasis in South Asia. Based on her team’s discovery and effort to address lead poisoning from turmeric in Bangladesh, she was named one of the 100 most influential people in Global Health by Time Magazine in 2024. Prior to studying lead contamination and poisoning, she spent nearly 10 years addressing global and environmental health problems from contaminants in the air, water, soil, and food. Her work has been featured in The Economist, The Washington Post, Vox, The Scientist, Undark, Think Global Health, Environmental Health News, Stanford Medicine, Effective Altruism and other outlets. She holds a PhD in Environment and Resources from Stanford University and a Master’s of Science in Engineering and Certificate in Global Health from the University of Washington.
-
Marina Francis
Postdoctoral Scholar, Radiation Therapy
BioDr. Francis is a Postdoctoral Scholar in Dr. Everett Moding’s lab at the Department of Radiation Oncology. She uses genomic analysis of patient samples and preclinical models to identify new targets that sensitize sarcoma to treatments like radiation and immunotherapy. Before joining Stanford University, she completed her PhD in Biomedical Sciences at the American University of Beirut, where she worked in Dr. Youssef Zeidan’s lab investigating the role of the sphingolipid-modifying enzyme SMPDL3b in radiation nephropathy. Her research interests revolve around improving cancer treatment outcomes and patients’ quality of life by optimizing radiation therapy, combined treatment strategies, personalized precision oncology, and mitigating collateral treatment-associated toxicities.
-
Joel Fundaun
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioJoel Fundaun is a clinician-scientist specializing in chronic pain following traumatic head and neck injuries. His research aims to identify the drivers of pain persistence and develop tools to better predict recovery after traumatic injuries. By integrating clinical phenotyping, neuroimaging, and molecular biomarkers, he investigates why some individuals develop chronic pain while others recover.
Joel earned his Doctor of Physical Therapy from Regis University and completed an Orthopaedic Physical Therapy Residency at Northwestern University–Shirley Ryan AbilityLab. He received his DPhil (PhD) in Clinical Neurosciences from the University of Oxford, where his doctoral research identified novel signs of nerve injury and neuropathic pain in whiplash-associated disorders.
Currently, he is a Postdoctoral Research Fellow at Stanford University. He also continues to work clinically as a physical therapist at the Stanford Pain Management Center, where he treats patients with complex chronic pain conditions. -
Yiming Gan
Postdoctoral Scholar, Neurology and Neurological Sciences
BioDr. Yiming Gan is a postdoctoral scholar in the Department of Neurology. He earned his B.S. degree in Modern Mechanics from the University of Science and Technology of China (USTC) in 2019 and his Ph.D. in Mechanical Engineering from the University of Rochester in 2024, where his research focused on the experimental measurement and computational modeling of cerebrospinal fluid flow and the glymphatic system. After graduation, he joined Stanford University as a postdoctoral scholar in the Pediatric Neurostimulation Laboratory (Baumer Lab) and the Wu Tsai Neuroscience Institute. His research interests span biomarkers for epilepsy (functional connectivity), cerebral drug delivery, and Laser Interstitial Thermal Therapy.
-
Christina Gangemi
Postdoctoral Scholar, Developmental Biology
BioDr Christina Gangemi received her undergraduate degree from Monash University (2016) specialising in molecular biology and biochemistry. She became an Undergraduate Research Opportunities Program Scholar (2016) and completed her Honours thesis (2017) at the Australian Regenerative Medicine Institute (ARMI), Monash University. She later joined Professor Harald Janovjak’s group at ARMI (2018) as a research assistant before completing her doctorate degree (2019-2023) where she studied optical approaches to promote pancreatic beta cell regeneration. Key achievements from this work include establishing an automated image analysis approach to quantify islet proliferation assays, designing a modular light-emitting diode shelving system for ex vivo and in vitro illumination of primary islets, generating a new assay to test cyclin-dependent kinase 6 (CDK6) function (a known beta cell proliferation driver), and exploring the effects of photoswitchable pdDronpa domains when engineered into CDK6. During her candidature, she was awarded a Juvenile Diabetes Research Foundation Australia PhD Top-Up Scholarship. In 2023 she undertook a Postdoctoral Research Associate role in the Janovjak group at Flinders University and has recently joined Professor Seung Kim's group at Stanford University.
-
Yifan Gao
Postdoctoral Scholar, Microbiology and Immunology
BioDr. Yifan Gao is a postdoctoral researcher at Stanford University School of Medicine in the Department of Microbiology and Immunology under Prof. Justin Sonnenburg's advisement. Prior to joining Stanford, she received her Ph.D. from UCLA focusing on Environmental Microbiology and M.S. from UC Berkeley in Environmental Engineering.
-
Cathy Garcia
Postdoctoral Scholar, Stanford Cancer Institute
Current Research and Scholarly InterestsIslet biology, diabetes, obesity, pancreatic cancer
-
Benedikt Geier
Postdoctoral Scholar, Infectious Diseases
BioB.Sc. Biology, Ludwig Maximilian University (LMU), Munich/Germany (2013)
M.Sc. Biology and bioimaging, Ludwig Maximilian University (LMU), Munich/Germany (2015)
Ph.D., Animal-Microbe Symbioses, Max Planck Institute for Marine Microbiology in Bremen/Germany (2020)
Benedikt joined the Amieva Lab from Germany in 2022. During his B.Sc. and M.Sc. programs in zoology, he became fascinated with 3D imaging approaches to study small animal microanatomy. He spent his PhD developing in situ imaging approaches to study deep-sea symbioses and fell in love with studying host-microbe interactions. In the Amieva Lab, Benedikt will advance his previously developed correlative chemical imaging techniques to resolve metabolic and cellular interactions that drive H. pylori pathogenesis in the gastric glands.
More about Benedikt's transition from deep-sea microbiology into infectious disease research can be found here:
https://scopeblog.stanford.edu/2022/08/24/unconventional-paths-deep-sea-to-the-stomach/ -
Elias Roth Gerrick
Member, Maternal & Child Health Research Institute (MCHRI)
BioEli received his B.S. in Microbiology and Immunology from U.C. Irvine in 2013, where he worked in the lab of Dr. Celia Goulding. He earned his Ph.D. from Harvard University in 2018 in the lab of Dr. Sarah Fortune, where he studied post-transcriptional regulation of gene expression in Mycobacterium tuberculosis. Eli joined the Howitt lab at Stanford in the summer of 2018, where he is studying the influence of protozoan members of the microbiome on intestinal immunity.
-
Marc Ghanem
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsMarc's research focuses on leveraging deep learning to identify clinically relevant patterns within large medical datasets, aiming to deliver personalized and predictive healthcare solutions. Current projects include building comprehensive perioperative foundation model, optimizing neonatal total parenteral nutrition (TPN), analyzing anesthesiology research trends, and identifying differential responders and their characteristics in clinical trials.
-
Ruth Margaret Gibson
Visiting Scholar, Medicine - Primary Care and Population Health
Affiliate, Pediatrics - NeonatologyBioDr. Ruth Gibson, PhD (如詩 吉布森), is a scholar at Stanford University with appointments at the Center for Innovation and Global Health (CIGH) and the Center for International Security and Cooperation (CISAC) within the Freeman Spogli Institute for International Studies.
Dr. Gibson specializes in global health and foreign affairs with a dedicated focus on improving maternal and child health in geopolitically complex regions affected by war and geopolitical challenges.
She holds an Honour's Bachelor of Science and a Master of Science from the University of Toronto, a fellowship in Medical Education from the Wilson Center for Medical Education at the University Health Network, and a PhD in Global Health and Strategic Studies from the University of British Columbia, and a postdoctoral fellowship from Stanford University. Fluent in English and French, and proficient in Mandarin Chinese, Dr. Gibson has spent a decade living abroad, engaging in humanitarian and global health initiatives across eight countries on five continents. Her experience spans fragile regions grappling with poverty, human rights issues, and war.
Currently, she is co-leading a Lancet Series on Global Health and Foreign Engagement with Professor Gary Darmstadt. Recently, she published significant findings on the impact of foreign aid sanctions on maternal and child health in The Lancet Global Health, garnering attention in Nature Medicine, The Stanford Report, and numerous international media outlets due to its critical relevance in today’s geopolitical landscape.
Dr. Gibson collaborates with the United Nations High Commission for Human Rights to develop a universal monitoring system to assess the impact of sanctions on human rights. Her research has been cited in UN General Assembly meetings by the Special Rapporteur on Unilateral Coercive Measures. She also contributes to mental health reports for the International Criminal Court's prosecution of war crimes and collaborates with the Global Burden of Disease Consortium at the Institute of Health Metrics and Evaluation, University of Washington, to publish health estimations and forecasts in The Lancet.
Leading a diverse team of academic scholars and independent experts and consultants, Dr. Gibson fosters a collaborative environment that encourages participation across various fields, including politics, statistics, simulation modeling, and social media design. Together, they aim to tackle complex questions regarding how civilian and child well-being is impacted by geopolitical challenges and foreign policy decisions. Dr. Gibson welcomes inquiries from those interested in conducting interdisciplinary research with real-world impact. She is responsive to journalists and media outlets seeking to understand issues which fall at the intersection of geopolitics, foreign policy, and health.
Dr. Gibson can be reached at rmgibson (at) stanford.edu
https://drruthgibson.com/ -
Joshua Gillard
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Josh Gillard is a Canadian biomedical data scientist with experience in bioinformatics, machine learning, and immunology. After completing a BSc and a MSc in Experimental Medicine at McGill university, he relocated to the Netherlands for his PhD in bioinformatics at Radboud University in Nijmegen. During his PhD, he gained experience analyzing and interpreting complex immunological data (bulk and single-cell transcriptomics, high-dimensional cytometry, high-throughput proteomics) derived from human observational or intervention studies (vaccination and experimental human infection). This work revealed molecular and cellular correlates of clinically important endpoints such as disease severity, symptom progression, and antibody responses. In 2022, Josh relocated to Stanford to join the Gaudilliere lab to develop and apply multi-omic data integration and machine learning techniques, establishing that early gestational immune dysregulation can predict preterm birth. Since 2024, in the Ashley lab, Josh is developing deep learning models to investigate aberrant splicing in cardiovascular disease.
